PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Korean Journal of Ophthalmology10.3341/kjo.2020.0096202135126-36One-year Results of Aflibercept Treatment for Polypoidal Choroidal Vasculopathy with Good Visual AcuityJi Min Kwon, Kang Yeun Pak, Jae Jung Lee, Min Sagong, Hyun Woong Kimhttp://ekjo.org/upload/pdf/kjo-2020-0096.pdf, http://ekjo.org/journal/view.php?doi=10.3341/kjo.2020.0096, http://ekjo.org/upload/pdf/kjo-2020-0096.pdf
Japanese Journal of Ophthalmology10.1007/s10384-013-0245-92013574365-371Treatment results at 1 year of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good visual acuityRyusaburo Mori, Mitsuko Yuzawa, Eriko Akaza, Miho Haruyamahttp://link.springer.com/content/pdf/10.1007/s10384-013-0245-9.pdf, http://link.springer.com/article/10.1007/s10384-013-0245-9/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10384-013-0245-9
Ophthalmology10.1016/j.ophtha.2015.08.02620161232e13Re: Yamamoto et al.: One-year results of intravitreal aflibercept for polypoidal choroidal vasculopathy (Ophthalmology 2015;122:1866-72)Jae Hui Kimhttps://api.elsevier.com/content/article/PII:S0161642015008829?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S0161642015008829?httpAccept=text/xml
PLOS ONE10.1371/journal.pone.01970422018135e0197042Choroidal structure as a biomarker for visual acuity in intravitreal aflibercept therapy for polypoidal choroidal vasculopathyShotaro Asano, Keiko Azuma, Kimiko Shimizu, Risako Yamamoto, Jinhee Lee, Hiroshi Murata, Tatsuya Inoue, Ryo Asaoka, Ryo Obatahttp://dx.plos.org/10.1371/journal.pone.0197042
Ophthalmology10.1016/j.ophtha.2015.05.024201512291866-1872One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal VasculopathyAkiko Yamamoto, Annabelle A. Okada, Mariko Kano, Hideki Koizumi, Masaaki Saito, Ichiro Maruko, Tetsuju Sekiryu, Tomohiro Iidahttps://api.elsevier.com/content/article/PII:S0161642015005072?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S0161642015005072?httpAccept=text/xml
Acta Ophthalmologica10.1111/j.1755-3768.2016.0456201694Short-term efficacy of intravitreal aflibercept depending on subtypes of polypoidal choroidal vasculopathy: polypoidal choroidal neovascularization or idiopathic choroidal vasculopathyM. Sagong, S. Jeonghttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-3768.2016.0456, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2016.0456/fullpdf
PLOS ONE10.1371/journal.pone.02352132020156e0235213Comparison of one-year results of photodynamic therapy combined with ranibizumab or aflibercept for treating polypoidal choroidal vasculopathyArisa Ito, Maiko Maruyama-Inoue, Yoko Kitajima, Shimpei Sato, Tatsuya Inoue, Shin Yamane, Kazuaki Kadonosonohttps://dx.plos.org/10.1371/journal.pone.0235213
10.21203/rs.3.rs-51865/v12020One-Year Outcomes of Fixed-Dosing Aflibercept Therapy for Polypoidal Choroidal Vasculopathy: A Case SeriesHun Gu Choo, Jin Hae Lee, Hyun Sub Oh, Yong Sung You, Soon Hyun Kim, Oh Woong Kwonhttps://www.researchsquare.com/article/rs-51865/v1, https://www.researchsquare.com/article/rs-51865/v1.html
10.21203/rs.3.rs-51865/v32021One-year Outcomes of Fixed-Dosing Aflibercept Therapy for pre treated and naive polypoidal choroidal vasculopathy patientHun Gu Choo, Jin Hae Lee, Hyun Sub Oh, Yong Sung You, Soon Hyun Kim, Oh Woong Kwonhttps://www.researchsquare.com/article/rs-51865/v3, https://www.researchsquare.com/article/rs-51865/v3.html
10.21203/rs.3.rs-51865/v22020One-year Outcomes of Fixed-Dosing Aflibercept Therapy for pre treated and naive polypoidal choroidal vasculopathy patientHun Gu Choo, Jin Hae Lee, Hyun Sub Oh, Yong Sung You, Soon Hyun Kim, Oh Woong Kwonhttps://www.researchsquare.com/article/rs-51865/v2, https://www.researchsquare.com/article/rs-51865/v2.html